Short-term effects and attributable burden of ambient volatile organic compound mixtures on pediatric atopic

Minsun Lee1,2, Kyungjun Jeong1,2, Kyungnam Kim2

  • 1Institute for Environmental Research, College of Medicine, Yonsei University, Seoul, Republic of Korea.

Insights

Short-term exposure to volatile organic compounds (VOCs) is linked to increased pediatric asthma and atopic dermatitis (AD) in Seoul. Aromatic VOCs, especially toluene, were key contributors to this health burden.

Area of Science:

  • Environmental Health
  • Pediatric Epidemiology
  • Toxicology

Background:

  • Ambient volatile organic compounds (VOCs) are complex mixtures with poorly understood short-term health effects in children.
  • Pediatric respiratory and allergic diseases, such as asthma and atopic dermatitis (AD), are significant public health concerns.

Purpose of the Study:

  • To investigate the short-term associations between ambient VOC mixtures and pediatric atopic dermatitis (AD) and asthma in Seoul, South Korea.
  • To estimate the population-level attributable burden of these health outcomes due to VOC exposure.

Main Methods:

  • Utilized daily outpatient visit and hospital admission data for individuals under 19 years old in Seoul (2015-2019).
  • Linked health data with citywide VOC concentrations, categorized into n-alkanes (G1), branched/cyclo-alkanes (G2), alkenes/alkynes (G3), and aromatics (G4).
  • Employed Weighted Quantile Sum regression (WQSR) and Bayesian Kernel Machine Regression to analyze mixture effects and calculated Population Attributable Fractions (PAFs).

Main Results:

  • Ambient VOC mixtures were associated with increased daily visits and admissions for pediatric AD and asthma.
  • Toluene (aromatic, G4) exhibited the highest association weights for both AD and asthma.
  • Hexane (G1) and cyclohexane (G2) also showed significant associations, with estimated ecological PAFs for AD and asthma ranging from 4.0% to 7.0% under a reduced exposure scenario.

Conclusions:

  • Short-term exposure to ambient VOC mixtures, particularly aromatics like toluene, significantly increases the pediatric burden of AD and asthma in Seoul.
  • The findings highlight the potential for a measurable population-level health impact from VOC mixture exposure.
  • Further research is needed to elucidate the specific roles of various VOCs and their potential co-exposure with other pollutants.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: